Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 3
2005 12
2006 27
2007 19
2008 21
2009 28
2010 54
2011 72
2012 63
2013 55
2014 72
2015 91
2016 103
2017 114
2018 133
2019 162
2020 183
2021 223
2022 256
2023 230
2024 270
2025 343
2026 46

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,303 results

Results by year

Filters applied: . Clear all
Page 1
Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial.
Ludmir EB, Sherry AD, Fellman BM, Liu S, Bathala T, Haymaker C, Medina-Rosales MN, Reuben A, Holliday EB, Smith GL, Noticewala SS, Nicholas S, Price TR, Martin-Paulpeter RM, Perles LA, Lee SS, Lee MS, Smaglo BG, Huey RW, Willis J, Zhao D, Cohen L, Taniguchi CM, Koay EJ, Katz MHG, Wolff RA, Das P, Pant S, Koong AC, Tang C. Ludmir EB, et al. Among authors: zhao d. J Clin Oncol. 2024 Nov 10;42(32):3795-3805. doi: 10.1200/JCO.24.00081. Epub 2024 Aug 5. J Clin Oncol. 2024. PMID: 39102622 Free PMC article. Clinical Trial.
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial.
Cloughesy TF, van den Bent MJ, Touat M, Blumenthal DT, Peters KB, Ellingson BM, Clarke JL, Mendez J, Yust-Katz S, Welsh L, Mason WP, Ducray F, Umemura Y, Nabors B, Holdhoff M, Hottinger AF, Arakawa Y, Sepulveda JM, Wick W, Soffietti R, Perry J, Giglio P, de la Fuente M, Maher E, Bottomley A, Tron AE, Yi D, Zhao D, Pandya SS, Steelman L, Hassan I, Wen PY, Mellinghoff IK; INDIGO trial investigators. Cloughesy TF, et al. Among authors: zhao d. Lancet Oncol. 2025 Dec;26(12):1665-1675. doi: 10.1016/S1470-2045(25)00472-3. Epub 2025 Oct 29. Lancet Oncol. 2025. PMID: 41175888 Clinical Trial.
Nogo-B inhibition facilitates cholesterol metabolism to reduce hypercholesterolemia.
Xue C, Zeng P, Gong K, Li Q, Feng Z, Wang M, Chen S, Yang Y, Li J, Zhang S, Yin Z, Liang Y, Yan T, Yu M, Feng K, Zhao D, Yang X, Zhang X, Ma L, Iwakiri Y, Chen L, Tang X, Chen Y, Chen H, Duan Y. Xue C, et al. Among authors: zhao d. Cell Rep. 2024 Sep 24;43(9):114691. doi: 10.1016/j.celrep.2024.114691. Epub 2024 Sep 3. Cell Rep. 2024. PMID: 39235944 Free article.
KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma.
Yousef M, Yousef A, Hurd MW, Pillai A, Chowdhury S, Snyder R, Knafl M, Lewis RL, Roy PM, Fanaeian M, Albarouki S, Castelnovo LF, Peterson J, Smaglo BG, Wolff RA, Pant S, Willis J, Huey R, Overman M, Tzeng CW, Kim MP, Ikoma N, Maxwell JE, Katz MHG, Wang H, Maitra A, Koay E, Ludmir EB, Chen A, Lopez C, Ying H, Shen JP, Zhao D. Yousef M, et al. Among authors: zhao d. J Hematol Oncol. 2025 Apr 17;18(1):44. doi: 10.1186/s13045-025-01696-0. J Hematol Oncol. 2025. PMID: 40247392 Free PMC article.
Macrophage PD-1 regulates energy expenditure and metabolic dysfunction under immune checkpoint blockade.
Wu MM, Yang YC, Hu ZQ, Chang JY, Xiao H, Miao C, Zhang BW, He ZX, Zhu D, Duan YR, Wang S, Liu JY, Guo ZP, Sun Y, Liu DY, Yu M, Zhang Y, Mao JJ, Jiang S, Zhang BK, Mei Z, Gao J, Liang C, Wang QS, Yu CJ, Zhao D, Yan CH, Li Y, Pan ZW, Chen Z, Xu DQ, Liu T, Ji Y, Zhang ZR. Wu MM, et al. Among authors: zhao d. Cell Metab. 2026 Jan 6;38(1):208-227.e12. doi: 10.1016/j.cmet.2025.11.009. Epub 2025 Dec 10. Cell Metab. 2026. PMID: 41380676
2,303 results